Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Effect of Sample Transportation on the Proteome of Human Circulating Blood Extracellular Vesicles

(2022) Anne-Christine Uldry et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Bispecific antibodies in oncology

(2022) Arman Esfandiari et al.   NATURE REVIEWS DRUG DISCOVERY

FGFR4-targeted chimeric antigen receptors (CARs) combined with anti-myeloid poly-pharmacy effectively treats orthotopic rhabdomyosarcoma

(2022) Peter M. Sullivan et al.   MOLECULAR CANCER THERAPEUTICS

The B7-H3-targeting antibody-drug conjugate m276-SL-PBD is potently effective against pediatric cancer preclinical solid tumor models

(2021) Nathan M. Kendsersky et al.   CLINICAL CANCER RESEARCH

Unlocking the potential of antibody–drug conjugates for cancer therapy

(2021) Joshua Z. Drago et al.   Nature Reviews Clinical Oncology

Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy

(2021) Belén Blanco et al.   CLINICAL CANCER RESEARCH

Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease

(2021) Nathalie S.M. Lak et al.   CLINICAL CANCER RESEARCH

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

(2021) Jack F. Shern et al.   JOURNAL OF CLINICAL ONCOLOGY

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

(2021) András Lánczky et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma

(2021) Takuyo Kanayama et al.   Scientific Reports

Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion

(2021) Roxane R. Lavoie et al.   Cancers

Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies

(2021) Massimo Ganassi et al.   EXPERIMENTAL CELL RESEARCH

ProteomicsDB: toward a FAIR open-source resource for life-science research

(2021) Ludwig Lautenbacher et al.   NUCLEIC ACIDS RESEARCH

Immuno-transcriptomic profiling of extracranial pediatric solid malignancies

(2021) Andrew S. Brohl et al.   Cell Reports

Cell adhesion molecule 2 (CADM2) promotes brain metastasis by inducing epithelial-mesenchymal transition (EMT) in human non-small cell lung cancer

(2020) Lu Dai et al.   Annals of Translational Medicine

dream: Powerful differential expression analysis for repeated measures designs

(2020) Gabriel E Hoffman et al.   BIOINFORMATICS

Cell fusion is differentially regulated in zebrafish post-embryonic slow and fast muscle

(2020) Kimberly J. Hromowyk et al.   DEVELOPMENTAL BIOLOGY

Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions

(2020) Andrey D. Bondarev et al.   Expert Opinion on Drug Discovery

The Role of Glypicans in Cancer Progression and Therapy

(2020) Nan Li et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

(2020) Meenakshi Hegde et al.   Nature Communications

ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study

(2020) James I. Geller et al.   CANCER

Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell–Cell Interactions in Tumor Progression

(2020) Adam Lauko et al.   CANCER RESEARCH

Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity

(2020) Gabriele Manzella et al.   Nature Communications

Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies

(2020) David O. Azorsa et al.   MODERN PATHOLOGY

VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots

(2020) Joachim Goedhart et al.   Scientific Reports

CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors

(2019) Robbie G. Majzner et al.   CLINICAL CANCER RESEARCH

CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma

(2018) Dongliang Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Chimeric Antigen Receptor Therapy

(2018) Carl H. June et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer

(2018) John K. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CAR T cell immunotherapy for human cancer

(2018) Carl H. June et al.   SCIENCE

Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses

(2018) Elizabeth Stewart et al.   CANCER CELL

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer

(2018) Mari Hosonaga et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma

(2018) Suman Malempati et al.   CANCER

UniProt: a worldwide hub of protein knowledge

(2018)   NUCLEIC ACIDS RESEARCH

Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions

(2017) Madhurima Saha et al.   HUMAN MOLECULAR GENETICS

Regulation of body weight and energy homeostasis by neuronal cell adhesion molecule 1

(2017) Thomas Rathjen et al.   NATURE NEUROSCIENCE

ProteomicsDB

(2017) Tobias Schmidt et al.   NUCLEIC ACIDS RESEARCH

Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility

(2016) Annette Künkele et al.   CLINICAL CANCER RESEARCH

L1-CAM is commonly expressed in testicular germ cell tumours

(2016) Christian D Fankhauser et al.   JOURNAL OF CLINICAL PATHOLOGY

Long-term effect of chemotherapy–intensity-modulated radiation therapy (chemo-IMRT) on dentofacial development in head and neck rhabdomyosarcoma patients

(2016) Adepitan A. Owosho et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors

(2016) Shingo Inaguma et al.   Oncotarget

Abstract 2488: FGFR4 as a potential therapeutic target for monoclonal antibody based intervention in rhabdomyosarcoma

(2015) Sivasubramanian Baskar et al.   CANCER RESEARCH

Abstract 1680:In vitroandin vivoactivity of a highly potent and novel FGFR2/FGFR4 dual targeting antibody-drug conjugate

(2015) Matthew J. Meyer et al.   CANCER RESEARCH

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

Functional Tuning of CARs Reveals Signaling Threshold above Which CD8+ CTL Antitumor Potency Is Attenuated due to Cell Fas-FasL-Dependent AICD

(2015) A. Kunkele et al.   Cancer Immunology Research

Diverse Solid Tumors Expressing a Restricted Epitope of L1-CAM Can Be Targeted by Chimeric Antigen Receptor Redirected T Lymphocytes

(2014) Hao Hong et al.   JOURNAL OF IMMUNOTHERAPY

Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing

(2014) Shufang Zhang et al.   PLoS One

Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

(2014) J. F. Shern et al.   Cancer Discovery

Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression

(2013) Wei He et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways

(2013) Won-Suk Chung et al.   NATURE

Antibody–drug conjugates

(2013) Rachel S. Zolot et al.   NATURE REVIEWS DRUG DISCOVERY

Proteome remodelling during development from blood to insect-form Trypanosoma brucei quantified by SILAC and mass spectrometry

(2012) Kapila Gunasekera et al.   BMC GENOMICS

Targeting the fetal acetylcholine receptor in rhabdomyosarcoma

(2012) Katja Simon-Keller et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad?

(2012) Andrea Gombos et al.   INVESTIGATIONAL NEW DRUGS

Insights into the regulation of protein abundance from proteomic and transcriptomic analyses

(2012) Christine Vogel et al.   NATURE REVIEWS GENETICS

Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas

(2012) Douglas S. Hawkins et al.   PEDIATRIC BLOOD & CANCER

Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers

(2012) Rimas J. Orentas et al.   Frontiers in Oncology

Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling

(2011) Fuchuan Li et al.   JOURNAL OF CELL BIOLOGY

Jamb and Jamc Are Essential for Vertebrate Myocyte Fusion

(2011) Gareth T. Powell et al.   PLOS BIOLOGY

Hypoexpression and Epigenetic Regulation of Candidate Tumor Suppressor Gene CADM-2 in Human Prostate Cancer

(2010) G. Chang et al.   CLINICAL CANCER RESEARCH

Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma

(2010) Daniel Williamson et al.   JOURNAL OF CLINICAL ONCOLOGY

Muscling in: Uncovering the origins of rhabdomyosarcoma

(2010) Simone Hettmer et al.   NATURE MEDICINE

Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-xL

(2010) L H Mayeenuddin et al.   ONCOGENE

Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis

(2009) Elai Davicioni et al.   AMERICAN JOURNAL OF PATHOLOGY

Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma

(2009) S. Oesch et al.   MOLECULAR CANCER THERAPEUTICS

Microarray background correction: maximum likelihood estimation for the normal-exponential convolution

(2008) J. D. Silver et al.   BIOSTATISTICS

Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall

(2008) Armita Bahrami et al.   MODERN PATHOLOGY

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

(2008) Jürgen Cox et al.   NATURE BIOTECHNOLOGY